Position in GILD
as of Mar 31, 2026
· filed May 6, 2026
Position Value
$140,981,674
+$8,113,906 QoQ
Shares Held
1,011,564
-6.6% QoQ
Ownership
0.081%
of shares outstanding
% of Portfolio
0.13%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 10.317883989544903.ToString("F0")%
Shared 0.ToString("F0")%
None 89.68211601045509.ToString("F0")%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Derivatives in GILD
reported options exposure · as of Mar 31, 2026CallValue
$0
CallShares
0
PutValue
$334,488
PutShares
2,400
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026LPL Financial LLC holds $5,177,354,777 across 17 Drug Manufacturers - General names. GILD ranks #8 (2.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
4,898,849 | $1,197,474,649 | |
| 2 | LLY |
ELI LILLY & Co
|
1,196,696 | $1,100,685,079 | |
| 3 | ABBV |
AbbVie Inc.
|
3,945,266 | $858,055,902 | |
| 4 | MRK |
Merck & Co., Inc.
|
3,782,188 | $454,959,394 | |
| 5 | AMGN |
Amgen Inc
|
1,163,976 | $409,544,955 | |
| 6 | PFE |
Pfizer Inc
|
13,393,661 | $376,094,000 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
3,212,769 | $194,854,439 | |
| 8 | GILD |
Gilead Sciences, Inc.
This page
|
1,011,564 | $140,981,674 |
All Filings in GILD
Export CSV
28 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $334,488 | 2,400 | Put | Sole | 2026-05-06 | |
| 2026-03-31 | $140,981,674 | 1,011,564 | Shares | Sole | 2026-05-06 | |
| 2025-12-31 | $132,867,768 | 1,082,514 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $115,107,222 | 1,037,002 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $243,914 | 2,200 | Put | Sole | 2025-08-12 | |
| 2025-06-30 | $110,217,751 | 994,117 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $121,175,912 | 1,081,445 | Shares | Sole | 2025-05-07 | |
| 2025-03-31 | $358,560 | 3,200 | Put | Sole | 2025-05-07 | |
| 2024-12-31 | $111,441,818 | 1,206,472 | Shares | Sole | 2025-02-11 | |
| 2024-09-30 | $95,358,023 | 1,137,381 | Shares | Sole | 2024-11-08 | |
| 2024-06-30 | $72,626,566 | 1,058,542 | Shares | Sole | 2024-08-07 | |
| 2024-03-31 | $76,059,577 | 1,038,356 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $71,315,776 | 880,333 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $64,117,539 | 855,585 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $62,275,488 | 808,038 | Shares | Sole | 2023-07-31 | |
| 2023-03-31 | $75,286,314 | 907,392 | Shares | Sole | 2023-05-10 | |
| 2022-12-31 | $100,717,674 | 1,173,182 | Shares | Sole | 2023-02-07 | |
| 2022-09-30 | $68,956,896 | 1,117,797 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $61,997,284 | 1,003,030 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $48,432,666 | 814,679 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $55,752,644 | 767,837 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $49,794,668 | 712,880 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $44,368,150 | 644,324 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $39,491,579 | 611,041 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $35,093,493 | 602,360 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $34,342,122 | 543,474 | Shares | Sole | 2020-11-09 | |
| 2020-06-30 | $34,292,004 | 445,698 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $41,886,532 | 560,280 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||